{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:31:40Z","timestamp":1761921100281,"version":"3.40.5"},"reference-count":37,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Tobacco use and related mortality is common in people receiving opioid agonist treatment (OAT). Smoking cessation medications are available and e\u2010cigarettes are increasingly recommended for high risk populations. This study explores experience, knowledge and attitudes around smoking cessation medications (nicotine replacement therapy [NRT], bupropion and varenicline) and e\u2010cigarettes in patients and clinicians in two public Australian OAT clinics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cross\u2010sectional surveys of patients and clinicians and a randomly sampled retrospective medical record review. Patients were recruited through an advertisement in the clinic, and clinicians through advertisement at an educational session.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ninety\u2010one patients and 10 clinicians completed the surveys. Most patients had at least one quit attempt and 43% were currently trying to quit. There were high levels of exposure to NRT, lower levels with varenicline and very limited exposure to bupropion. Patients considered e\u2010cigarettes most helpful, but were more likely to consider using NRT. Few patients reported smoking cessation interventions from their clinicians. Most clinicians identified high tobacco use prevalence, considered this problematic, but reported\u00a0low rates of smoking cessation intervention. NRT was the preferred medication. E\u2010cigarettes were not considered helpful. Sixty\u2010six percent of the 140 records reviewed documented patients as smokers. Tobacco cessation medication was rarely discussed or provided.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>Patients report high rates of tobacco cessation planning, but low rates of intervention. Experience of varenicline and bupropion is limited. E\u2010cigarettes were preferred over varenicline and bupropion. Improving patient's and clinician's knowledge of\u00a0tobacco cessation medications could improve smoking cessation interventions and uptake of approved medications.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.13630","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T17:00:20Z","timestamp":1678122020000},"page":"1092-1103","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["How do patients and staff in an opioid agonist treatment service view smoking cessation medications and e\u2010cigarettes?"],"prefix":"10.1111","volume":"42","author":[{"given":"Catherine","family":"Lobbe","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health University of New England  Armidale Australia"},{"name":"School of Medicine and Public Health The University of Newcastle  Newcastle Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade","family":"Bahnisch","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health University of New England  Armidale Australia"},{"name":"School of Medicine and Public Health The University of Newcastle  Newcastle Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Lin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health University of New England  Armidale Australia"},{"name":"School of Medicine and Public Health The University of Newcastle  Newcastle Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7937-7948","authenticated-orcid":false,"given":"Apo","family":"Demirkol","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-3025","authenticated-orcid":false,"given":"Bridin","family":"Murnion","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health The University of Newcastle  Newcastle Australia"},{"name":"Faculty of Medicine and Health UNSW Sydney  Sydney Australia"},{"name":"Faculty of Medicine and Public Health The University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874473711306010009"},{"key":"e_1_2_10_3_1","unstructured":"Australian Instiutte of Health and Welfare.Alcohol tobacco & other drugs in Australia. Canberra: AIHW; 2020. Retrieved 2022 Sept 14. Available from:https:\/\/www.aihw.gov.au\/reports\/alcohol\/alcohol-tobacco-other-drugs-australia"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12337"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1342661"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntx113"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.07.005"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12631"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0018649"},{"key":"e_1_2_10_10_1","article-title":"Electronic cigarettes for smoking cessation","volume":"11","author":"Hartmann\u2010Boyce J","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305107"},{"key":"e_1_2_10_12_1","unstructured":"Nicotine vaping products: Information for prescribers.Therapeutic goods administration Australian Government Department of Health and Aged Care; 2022. Retrieved 2022 Sept 14.\u00a0Available from:https:\/\/www.tga.gov.au\/nicotine\u2010vaping\u2010products\u2010information\u2010prescribers"},{"key":"e_1_2_10_13_1","unstructured":"Royal Australian College of General Practitioners.Pharmacotherapy for smoking cessation. Retrieved 14\u00a0\u00a0September\u00a02022. Available from:https:\/\/www.racgp.org.au\/clinical\u2010resources\/clinical\u2010guidelines\/key\u2010racgp\u2010guidelines\/view\u2010all\u2010racgp\u2010guidelines\/supporting\u2010smoking\u2010cessation\/pharmacotherapy\u2010for\u2010smoking\u2010cessation"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13005"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-304"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.55.11.1258"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2015.06.001"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2006.01.006"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.04.003"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230500170282"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.04.001"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v21n02_04"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.03.002"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7107.520"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01805.x"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.1995.1065"},{"issue":"3","key":"e_1_2_10_27_1","article-title":"Methods of the international tobacco control (ITC) four country survey","volume":"15","author":"Thompson ME","year":"2006","journal-title":"Tob Control"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000356"},{"key":"e_1_2_10_29_1","first-page":"237","article-title":"Measuring smoking knowledge, attitudes and services (S\u2010KAS) among clients in addiction treatment","volume":"114","author":"Guydish J","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0034389"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-8-13"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"e_1_2_10_33_1","unstructured":"Australian Institute of Health and Welfare.National Opioid Pharmacotherapy Statistics Annual Data collection. Canberra: AIHW; 2021."},{"key":"e_1_2_10_34_1","article-title":"Antidepressants for smoking cessation","volume":"4","author":"Hughes JR","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11414-020-09712-6"},{"key":"e_1_2_10_36_1","first-page":"280","article-title":"Electronic cigarettes in the media","volume":"29","author":"Payne JD","year":"2016","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2017.1343076"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/0959523021000059857"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13630","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.13630","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T08:08:46Z","timestamp":1692346126000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.13630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1111\/dar.13630"],"URL":"https:\/\/doi.org\/10.1111\/dar.13630","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"type":"print","value":"0959-5236"},{"type":"electronic","value":"1465-3362"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"assertion":[{"value":"2022-09-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}